Other OTC - Delayed Quote USD

Manhattan Scientifics, Inc. (MHTX)

0.0014 -0.0003 (-17.65%)
At close: 11:33 AM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Marvin Maslow Founder & Chairman of the Board -- -- 1938
Mr. Emmanuel Tsoupanarias President, CEO & Director 186k -- 1953
Mr. Leonard C. Friedman Secretary -- -- 1938
Mr. Robert Romeo Proulx President of Imagion 250k -- 1958

Manhattan Scientifics, Inc.

244 Fifth Avenue
Suite 2341
New York, NY 10001
United States
212 541 2405 https://www.mhtx.com
Sector: 
Healthcare
Industry: 
Medical Devices

Description

Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

Corporate Governance

Manhattan Scientifics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 06, 2024 - May 10, 2024
Manhattan Scientifics, Inc. Earnings Call